Media hub

Dr Mark Schreuder, a researcher at the Centenary Institute’s Centre for Cancer Innovations, has received the Kenyon Foundation Inflammation Award for 2024.

New research from the Centenary Institute has identified specific blood fats that can predict how effectively individuals with pre-diabetes will improve their blood sugar levels through diet and weight loss. These findings could pave the way for more personalised approaches to preventing and managing type 2 diabetes.

An international research group led by the Centenary Institute has developed a new genetic risk prediction tool to identify heavy drinkers most at risk of developing alcohol-associated cirrhosis, a severe form of liver disease.

The Centenary Institute has announced the winners of its ‘When Art Meets Science’ scientific image prize. The annual prize celebrates the artistic masterpieces captured by Centenary Institute researchers in the course of their ground-breaking medical research.

Researchers from the Centenary Institute and the University of Sydney have made a major discovery in vaccine science, gaining new insights into delta inulin as a crucial vaccine component. Their findings offer a promising pathway for advancing the next generation of vaccines.

Research conducted by the Centenary Institute has revealed a promising new approach to tackling melanoma, an aggressive form of skin cancer notorious for its resistance to conventional treatments.

The Centenary Institute has received vital grant funding from Cancer Australia to lead new research efforts targeting chemotherapy resistance in ovarian cancer patients.

The Centenary Institute’s Professor Jennifer Gamble has been awarded a Senior Researcher Grant under the NSW Cardiovascular Research Capacity Program receiving a total of $750,000 over three years. The grant will fund Professor Gamble’s research into vascular (blood vessel) health to aid healthy ageing and to help prevent disease.

Research led by the Centenary Institute, the University of Technology Sydney and the Hunter Medical Research Institute suggests that the gut microbiome plays a pivotal role in the development of chronic obstructive pulmonary disease (COPD), paving the way for new therapeutic treatments.

Researchers at the Centenary Institute have made an important breakthrough in understanding how the immune system fights off infections in the liver – paving the way for more specific and effective therapies to treat and prevent liver diseases such as viral hepatitis and fatty liver disease, and decrease the risk of liver transplant rejection.

Professor Philip Hogg, researcher in the Centenary Institute's Centre for Cancer Innovations, has received a National Health and Medical Research Council (NHMRC) Investigator Grant to undertake research aimed at revolutionising the treatment of haemophilia A.

Centenary Institute researchers have successfully secured over $2 million in combined funding from the Federal Government in the latest round of National Health and Medical Research Council (NHMRC) Ideas Grants.